Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 Infection
Clinical trial NCT04359680 · COMPLETED
Trial details
- NCT number
- NCT04359680
- Sponsor
- Romark Laboratories L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-13
- Primary completion
- 2021-04-07
- Enrollment
- 1407
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.